TRANSFORMATIVEMED INC. — Form D
TRANSFORMATIVEMED INC. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2022-05-06. The offering totals $1.2M, of which $1.2M was reported sold. Industry: Other Technology.
Offering
- Filed: 2022-05-06
- Form: D
- Accession: 0001543836-22-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $1.2M
- Amount sold: $1.2M
- Investors: 33
- Date of first sale: 2022-04-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-444878
Issuer
- Name: TRANSFORMATIVEMED INC.
- CIK: 0001543836
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 3131 Elliot Ave, SEATTLE, WA, 98121
- Phone: 206-457-8642
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Nathan Bays | Director | Seattle, WA |
| Shawn DeWane | Director | Seattle, WA |
| Joel Mezistrano | Director | Seattle, WA |
| Daniel Rosen | Director | San Francisco, CA |
| David Stone | Director | New York, NY |
| Shawn DeWane | Executive Officer | Seattle, WA |
| David Stone | Executive Officer | New York, NY |
| Erik Van Eaton | Executive Officer | Seattle, WA |
| Peter Weiss | Executive Officer | Seattle, WA |
| Erik Van Eaton | Director | Seattle, WA |
| Douglas Cusick | Director | Seattle, WA |
| Douglas Cusick | Executive Officer | Seattle, WA |
Other filings by this issuer (1)
More